REQUEST A DEMO
Total
USD $0.00
Search more companies

Krka-farma D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Krka-farma D.O.O. Beograd Profile Updated: June 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Krka-Farma D.O.O. is a pharmaceutical company located in Belgrade. The company has more than 12,500 employees who are dedicated to the quality, innovation, development, production, marketing, and sales of their pharmaceutical products. These products are trusted by over 50 million patients in more than 70 countries worldwide.

Headquarters
Jurija Gagarina 26/v/ Ii
Beograd-Grad; Beograd (Grad);

Contact Details: Purchase the Krka-farma D.O.O. Beograd report to view the information.

Website: http://www.krka.biz

Basic Information
Total Employees:
Purchase the Krka-farma D.O.O. Beograd report to view the information.
Outstanding Shares:
Purchase the Krka-farma D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Krka-farma D.O.O. Beograd report to view the information.
Financial Auditors:
Purchase the Krka-farma D.O.O. Beograd report to view the information.
Incorporation Date:
February 25, 1992
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Krka-farma D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
17.08%
Total operating revenue
16.84%
Operating profit (EBIT)
13.06%
EBITDA
11.93%
Net Profit (Loss) for the Period
17.42%
Total assets
31.71%
Total equity
20.16%
Operating Profit Margin (ROS)
-0.11%
Net Profit Margin
0%
Return on Equity (ROE)
-0.39%
Debt to Equity Ratio
5.83%
Quick Ratio
-0.17%
Cash Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?